Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Turkey Grapples With Spinraza Cost As Patients Seek Access

Feb 17 2017

• By Ahmet Sevindik

Turkey

Related Content

Biogen Forecasts Gradual Launch For Life-Transforming Drug Spinraza

Jan 26 2017

Biogen/Ionis’s Spinraza Approved; Second Antisense Drug For Neurodegeneration In 2016

Dec 28 2016

Keeping Track: US FDA Approves Spinraza And Rubraca, Delays Ocrevus; Plus Submissions Galore

Dec 27 2016

Related Companies

Biogen, Inc.

Ionis Pharmaceuticals, Inc.

Additional Topics

Turkey Europe Pricing Debate Policy Reimbursement Neurology BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window